Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2016

01.03.2016 | Original Article

Serological Assessment for Leishmania donovani Infection in Blood Donors of Sunsari District, Dharan, Nepal

verfasst von: Suraj Timilsina, Narayan Raj Bhattarai, Basudha Khanal, Suman Rijal

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Visceral leishmaniasis (VL) is a major vector-borne disease caused by Leishmania donovani, after replication of the parasites in macrophages, mononuclear phagocytic system. VL is endemic in 12 districts of central and eastern Terai lowlands of Nepal bordering North Bihar, India with an estimated 8 million population at risk. In addition, VL endemicity is also extending to new endemic regions like Dharan from its classical rural foci. Hence, we aimed to detect the evidence of Leishmania donovani infection in the blood samples received from blood donors of Sunsari district, Dharan, (eastern Nepal), a region endemic for human VL. Sera from 507 asymptomatic blood donors were subjected to serological screening for anti-Leishmania donovani antibodies. Direct agglutination test (DAT) was performed on the sera. Out of 507 donors, majority (78.50 %) were male. Among the donors, 472 (93.10 %) belonged to age group 18–45 years where as 35 (6.90 %) to age group >45 years. Circulating anti-Leishmania antibodies were detected in 5 (1 %) out of 507 healthy, Human Immunodeficiency Virus types 1 and 2 (HIV 1and 2), Hepatitis B Surface Antigen (HBsAg), anti- Hepatitis C Virus (anti-HCV)-negative, and Syphillis non-reactive donors. All the seropositive cases were male and belonged to the age group 18–45 years. The result suggests that there is an immediate need of screening asymptomatic blood donors for leishmania seropositivity especially in endemic areas.
Literatur
1.
Zurück zum Zitat Pearson RD, Sousa AQ (1995) Clinical spectrum of leishmaniasis. Clin Infect Dis 22:1–13CrossRef Pearson RD, Sousa AQ (1995) Clinical spectrum of leishmaniasis. Clin Infect Dis 22:1–13CrossRef
2.
Zurück zum Zitat Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6:849–854CrossRefPubMed Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6:849–854CrossRefPubMed
3.
Zurück zum Zitat Bista MB (1998) National overview of kala-azar in Nepal. In: Bastola S, Karki P, Rijal S, Gautam A (eds) Kala-azar in Nepal: principals, practice and public health perspectives. EDCD/BPKIHS/WHO, Kathmandu, pp 1–5 Bista MB (1998) National overview of kala-azar in Nepal. In: Bastola S, Karki P, Rijal S, Gautam A (eds) Kala-azar in Nepal: principals, practice and public health perspectives. EDCD/BPKIHS/WHO, Kathmandu, pp 1–5
4.
Zurück zum Zitat Rijal S, Uranw S, Chappuis F et al (2010) Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med and Int Health 15(2):21–28CrossRef Rijal S, Uranw S, Chappuis F et al (2010) Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med and Int Health 15(2):21–28CrossRef
5.
Zurück zum Zitat Chappuis F, Sundar S, Hailu A et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873–882CrossRefPubMed Chappuis F, Sundar S, Hailu A et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873–882CrossRefPubMed
6.
Zurück zum Zitat Xavier B (2003) USA blocks blood donation in bid to prevent leishmaniasis. Lanc Infect Dis 3:746 Xavier B (2003) USA blocks blood donation in bid to prevent leishmaniasis. Lanc Infect Dis 3:746
7.
Zurück zum Zitat Meredith SE, Kroon NC, Sondorp E et al (1995) Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol 33:1742–1745PubMedCentralPubMed Meredith SE, Kroon NC, Sondorp E et al (1995) Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol 33:1742–1745PubMedCentralPubMed
8.
Zurück zum Zitat Boelaert M, Rijal S, Regmi S et al (2004) A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg 70:72–77PubMed Boelaert M, Rijal S, Regmi S et al (2004) A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg 70:72–77PubMed
9.
Zurück zum Zitat Zijlstra EE, El-Hassan AM, Ismael A et al (1994) Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51:826–836PubMed Zijlstra EE, El-Hassan AM, Ismael A et al (1994) Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51:826–836PubMed
11.
Zurück zum Zitat Hasker E, Malaviya P, Gidwani K et al (2014) Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis 5:e1405. doi:10.1371/journal.pntd.0002657 Hasker E, Malaviya P, Gidwani K et al (2014) Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis 5:e1405. doi:10.​1371/​journal.​pntd.​0002657
12.
Zurück zum Zitat Scarlata F, Vitale F, Saporito L, Reale S et al (2008) Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 102:394–396CrossRefPubMed Scarlata F, Vitale F, Saporito L, Reale S et al (2008) Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 102:394–396CrossRefPubMed
13.
Zurück zum Zitat Fakhar M, Motazedia MH, Hatam GR et al (2008) Asymptomatic human carriers of Leishmania infantum: possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran. Ann Trop Med Parasitol 102:577–583CrossRefPubMed Fakhar M, Motazedia MH, Hatam GR et al (2008) Asymptomatic human carriers of Leishmania infantum: possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran. Ann Trop Med Parasitol 102:577–583CrossRefPubMed
14.
Zurück zum Zitat Riera C, Fisa R, Udina M et al (2004) Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg 98:102–110CrossRefPubMed Riera C, Fisa R, Udina M et al (2004) Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg 98:102–110CrossRefPubMed
15.
Zurück zum Zitat Le Fichoux Y, Quaranta JF, Aufeuvre JP et al (1999) Ocurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in Southern France. J Clin Microbiol 37:1953–1957PubMedCentralPubMed Le Fichoux Y, Quaranta JF, Aufeuvre JP et al (1999) Ocurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in Southern France. J Clin Microbiol 37:1953–1957PubMedCentralPubMed
16.
Zurück zum Zitat Luz KG, da Silva VD, Gomes EM et al (1997) Prevalence of anti-leishmania donovani antibody among brazilian blood donors and multiply transfused hemodialysis patients. Am J Trop Med Hyg 57(2):168–171PubMed Luz KG, da Silva VD, Gomes EM et al (1997) Prevalence of anti-leishmania donovani antibody among brazilian blood donors and multiply transfused hemodialysis patients. Am J Trop Med Hyg 57(2):168–171PubMed
17.
Zurück zum Zitat Riera C, Fisa R, López-Chejade P et al (2008) Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfus 48:1383–1398CrossRef Riera C, Fisa R, López-Chejade P et al (2008) Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfus 48:1383–1398CrossRef
19.
Zurück zum Zitat Guevara P, Rojas L, Gonzales N (1994) Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. Clin Diagn Lab Immun 1:385–389 Guevara P, Rojas L, Gonzales N (1994) Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. Clin Diagn Lab Immun 1:385–389
20.
Zurück zum Zitat Sharma MC, Gupta AK, Das VN (2000) Leishmania donovani in blood smears of symptomatic persons. Acta Trop 76:195–196CrossRefPubMed Sharma MC, Gupta AK, Das VN (2000) Leishmania donovani in blood smears of symptomatic persons. Acta Trop 76:195–196CrossRefPubMed
21.
Zurück zum Zitat Chung HL, Chow HK, Lu JP (1948) The first two cases of transfusion kala-azar. Chin Med J 66:325–326 Chung HL, Chow HK, Lu JP (1948) The first two cases of transfusion kala-azar. Chin Med J 66:325–326
22.
Zurück zum Zitat Singh S, Chaudhry VP, Wali JP (1996) Transfusion-transmitted kala-azar in India. Transfus 36:848–849CrossRef Singh S, Chaudhry VP, Wali JP (1996) Transfusion-transmitted kala-azar in India. Transfus 36:848–849CrossRef
23.
Zurück zum Zitat Mathur P, Samantaray JC (2004) The first probable case of platelet transfusion- transmitted visceral leishmaniasis. Transfus Med 14:319–321CrossRefPubMed Mathur P, Samantaray JC (2004) The first probable case of platelet transfusion- transmitted visceral leishmaniasis. Transfus Med 14:319–321CrossRefPubMed
25.
Zurück zum Zitat Antinori S, Cascio A, Parravicini C et al (2008) Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8:191–199CrossRefPubMed Antinori S, Cascio A, Parravicini C et al (2008) Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8:191–199CrossRefPubMed
26.
Zurück zum Zitat Dey A, Singh S (2006) Transfusion transmitted leishmaniasis: a case report and review of the literature. Indian J Med Microbiol 24:165–170PubMed Dey A, Singh S (2006) Transfusion transmitted leishmaniasis: a case report and review of the literature. Indian J Med Microbiol 24:165–170PubMed
27.
Zurück zum Zitat Kyriakou DS, Alexandrakis MG, Passam FH et al (2003) Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas? Transfus Med 13(2):59–62CrossRefPubMed Kyriakou DS, Alexandrakis MG, Passam FH et al (2003) Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas? Transfus Med 13(2):59–62CrossRefPubMed
Metadaten
Titel
Serological Assessment for Leishmania donovani Infection in Blood Donors of Sunsari District, Dharan, Nepal
verfasst von
Suraj Timilsina
Narayan Raj Bhattarai
Basudha Khanal
Suman Rijal
Publikationsdatum
01.03.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0505-6

Weitere Artikel der Ausgabe 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.